Who should be accountable for patient data access in connected healthcare hubs?

Clinical leadership, IAM teams, and supplier owners all share accountability, but the security function must make that accountability measurable. Every access path should be tied to an owner, a purpose, and a review point. If those cannot be shown in audit evidence, then the access model is not governed, only assumed.

Why This Matters for Security Teams

Connected healthcare hubs create a three-way accountability problem: clinical owners understand patient workflow, IAM teams understand entitlements, and supplier owners understand how external systems actually touch data. If those roles are not joined up, patient access becomes a chain of assumptions rather than a governed control. That matters because NHI risk is already a dominant breach path; the Ultimate Guide to NHIs notes that 80% of identity breaches involved compromised non-human identities such as service accounts and API keys, and 97% carry excessive privileges.

For healthcare, the question is not only who can see data, but who can prove why access existed, who approved it, and who must revoke it when the purpose ends. That is why this problem spans governance, operations, and vendor oversight. OWASP also flags non-human identity abuse as a distinct control gap in its OWASP Non-Human Identity Top 10, especially where service-to-service access is loosely owned and weakly reviewed. In practice, many security teams discover the missing owner only after a supplier integration has already been granted broad access to live patient records.

How It Works in Practice

The most workable model is shared accountability with explicit control ownership. Clinical leadership should own the data use case, IAM should own the access mechanism, and supplier owners should own the external dependency or integration. Security’s role is to make those responsibilities measurable through evidence: access purpose, approved scope, review interval, and revocation path. Current guidance suggests that patient data access should be treated as a high-risk entitlement, not a static role assignment.

That means each connected hub should maintain an access register that maps every non-human identity to:

• the patient workflow or clinical service it supports
• the business and clinical owner responsible for legitimacy
• the technical custodian responsible for implementation
• the review point for recertification and offboarding

Where possible, use short-lived credentials, workload identity, and purpose-bound authorisation instead of long-lived shared secrets. NHI Mgmt Group’s Ultimate Guide to NHIs — Key Research and Survey Results highlights that only 5.7% of organisations have full visibility into service accounts, which makes accountability hard to prove and harder to audit. A practical healthcare control set should therefore combine IAM review with clinical data governance, supplier contracts, and incident response playbooks. This aligns with the OWASP Non-Human Identity Top 10 and the broader need to manage access by purpose rather than by convenience. These controls tend to break down when legacy interfaces, shared service accounts, or outsourced platform teams can grant access outside the normal approval path.

Common Variations and Edge Cases

Tighter accountability often increases operational overhead, requiring organisations to balance auditability against care-delivery speed. That tradeoff is real in emergency access, imaging workflows, and cross-organisation referrals, where rigid approval chains can delay treatment. Best practice is evolving here: there is no universal standard for one perfect ownership model, but there is broad agreement that exceptions must be time-bound, logged, and reviewable.

One common edge case is the supplier-managed integration where the vendor operates the interface but the healthcare provider still owns the patient data outcome. In that situation, vendor access should never imply vendor accountability for the clinical decision to expose data. Another edge case is shared infrastructure across multiple hospitals or clinics, where accountability must be partitioned by data domain and tenant rather than by platform team alone. The governance answer is usually to assign a named clinical owner, a named technical owner, and a named supplier contact for every access path, then require evidence that each can revoke or justify it independently. For healthcare environments that operate under strict security and resilience obligations, this model also supports alignment with the OWASP Non-Human Identity Top 10 and the control discipline reflected in NHI research. Where this breaks down fastest is in emergency-response pathways that were never formally documented but have become the default way patient systems are accessed.

Related resources from NHI Mgmt Group

• Who is accountable when a connected app grants unauthorised access to data?
• How should healthcare organisations control access to patient data effectively?
• Who is accountable when healthcare data is exposed through weak access governance?
• Who is accountable when patient data is exposed through weak access control?